These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24355031)

  • 1. Atazanavir-based therapy with pegylated interferon and ribavirin for patients with hepatitis C and HIV.
    Rivero-Juarez A; Lopez-Cortes LF; Girón-Gonzalez JA; Pineda JA; Rivero A;
    Lancet Infect Dis; 2014 Jan; 14(1):13-14. PubMed ID: 24355031
    [No Abstract]   [Full Text] [Related]  

  • 2. Boceprevir for HCV in patients with HIV: where next?
    Osinusi A; Naggie S
    Lancet Infect Dis; 2013 Jul; 13(7):563-4. PubMed ID: 23768748
    [No Abstract]   [Full Text] [Related]  

  • 3. Safe co-administration of raltegravir, pegylated-interferon and, ribavirin in HIV individuals with hepatitis C virus-related liver damage.
    Moreno A; Quereda C; Fortún J; Bárcena R; Pérez-Elías MJ; Casado JL; Rodríguez-Sagrado MA; Mateos ML; Blesa C; Moreno S
    AIDS; 2010 May; 24(8):1231-3. PubMed ID: 20421744
    [No Abstract]   [Full Text] [Related]  

  • 4. Which is the real efficacy of pegylated interferon alpha 2a or 2b plus ribavirin in HCV infected patients with advanced fibrosis?
    Pellicelli AM; Romano M; Guarascio P; Vignally P
    J Hepatol; 2012 Sep; 57(3):704-5. PubMed ID: 22510262
    [No Abstract]   [Full Text] [Related]  

  • 5. The "pegylated" story continues--perhaps because both ends (α2a and α2b) are true?
    Reiberger T; Peck-Radosavljevic M
    J Hepatol; 2012 Jul; 57(1):226-8; author reply 229. PubMed ID: 22390901
    [No Abstract]   [Full Text] [Related]  

  • 6. Pegylated interferon (alone or with ribavirin) for chronic hepatitis C in haemodialysis population.
    Espinosa M; Hernàndez J; Arenas MD; Carnicer F; Caramelo C; Fabrizi F
    Kidney Blood Press Res; 2015; 40(3):258-65. PubMed ID: 25997572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A modified ribavirin-free interferon therapy with boceprevir in post-liver transplant recurrent hepatitis C.
    Maticic M; Luznik Z; Stepec S; Popovic P; Snedec N; Poljak M; Stanisavljevic D
    J Clin Gastroenterol; 2014; 48(5):464-5. PubMed ID: 24275712
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pegylated interferon plus ribavirin in chronic hepatitis C. More than half of patients show a lasting response].
    Zeuzem S
    MMW Fortschr Med; 2002 Feb; 144(8):30-4. PubMed ID: 11910820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One step forward in understanding the differences in antiviral response to interferon a2a and a2b in chronic hepatitis C patients with advanced fibrosis.
    Shouval D
    J Hepatol; 2012 Feb; 56(2):303-4. PubMed ID: 22015961
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment for hepatitis C virus with pegylated interferon-α plus ribavirin induces anti-atherogenic effects on cardiovascular risk biomarkers in HIV-infected and -uninfected patients.
    Masiá M; Robledano C; López N; Escolano C; Gutiérrez F
    J Antimicrob Chemother; 2011 Aug; 66(8):1861-8. PubMed ID: 21622971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HCV therapy with daclatasvir, PEG-IFN, and RBV after boceprevir-based therapy failure post-liver transplantation in hyper-IgM syndrome.
    Reddy KR; Wirjosemito A; Pavri TM; Sinese L
    Transplantation; 2014 Apr; 97(8):e47-8. PubMed ID: 24732900
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis C viral kinetics as a determinant of stopping pegylated interferon and ribavirin in genotype 1 infection.
    Kim DY
    Gut Liver; 2014 Jul; 8(4):335-6. PubMed ID: 25071896
    [No Abstract]   [Full Text] [Related]  

  • 13. Weight-based ribavirin with pegylated interferon alfa 2b: benefits, risks, and the origin of the evidence.
    Hrachovec J; Patel P
    Gastroenterology; 2003 Jun; 124(7):2003-4; author reply 2004-5. PubMed ID: 12812198
    [No Abstract]   [Full Text] [Related]  

  • 14. Interferon-alpha in treatment of chronic hepatitis C in co-infected HIV-patients in combination with ribavirin and as a pre-load therapy in treatment-naive HIV-positive patients. 8th European Conference on Clinical Aspects and Treatment of HIV Infection (8th ECCATH), 29-31 October, Athens Greece.
    Tossing G
    Eur J Med Res; 2002 Jan; 7(1):44-6. PubMed ID: 11827840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Summaries for patients. Pegylated interferon with or without ribavirin for patients with hepatitis C receiving hemodialysis.
    Ann Intern Med; 2013 Dec; 159(11):I-14. PubMed ID: 24297207
    [No Abstract]   [Full Text] [Related]  

  • 16. Response-guided boceprevir-based triple therapy in HIV/HCV-coinfected patients: the HIVCOBOC-RGT study.
    Mandorfer M; Steiner S; Schwabl P; Payer BA; Aichelburg MC; Lang G; Grabmeier-Pfistershammer K; Trauner M; Peck-Radosavljevic M; Reiberger T
    J Infect Dis; 2015 Mar; 211(5):729-35. PubMed ID: 25214517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pegylated interferon-alfa plus ribavirin therapies for chronic hepatitis C.
    Kanda T; Yokosuka O
    JNMA J Nepal Med Assoc; 2011; 51(181):41-8. PubMed ID: 22335095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: a prospective cohort study.
    Castells L; Rimola A; Manzardo C; Valdivieso A; Montero JL; Barcena R; Abradelo M; Xiol X; Aguilera V; Salcedo M; Rodriguez M; Bernal C; Suarez F; Antela A; Olivares S; Del Campo S; Laguno M; Fernandez JR; de la Rosa G; Agüero F; Perez I; González-García J; Esteban-Mur JI; Miro JM;
    J Hepatol; 2015 Jan; 62(1):92-100. PubMed ID: 25127748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chorea during treatment with pegylated interferon and ribavirin in HIV-HCV coinfected patient].
    Montes ML; Fraile JM; González JJ; Arribas JR
    Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):60-1. PubMed ID: 19218008
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current indications for triple therapy in hepatitis C virus infection].
    Molina Pérez E; Fernández Castroagudín J; Domínguez Muñoz E
    Gastroenterol Hepatol; 2012 Apr; 35(4):266-77. PubMed ID: 22410706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.